1. Home
  2. CRI vs WVE Comparison

CRI vs WVE Comparison

Compare CRI & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRI
  • WVE
  • Stock Information
  • Founded
  • CRI 1865
  • WVE 2012
  • Country
  • CRI United States
  • WVE Singapore
  • Employees
  • CRI N/A
  • WVE N/A
  • Industry
  • CRI Apparel
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRI Consumer Discretionary
  • WVE Health Care
  • Exchange
  • CRI Nasdaq
  • WVE Nasdaq
  • Market Cap
  • CRI 1.5B
  • WVE 1.7B
  • IPO Year
  • CRI 2003
  • WVE 2015
  • Fundamental
  • Price
  • CRI $41.06
  • WVE $7.74
  • Analyst Decision
  • CRI Hold
  • WVE Strong Buy
  • Analyst Count
  • CRI 4
  • WVE 11
  • Target Price
  • CRI $49.00
  • WVE $22.00
  • AVG Volume (30 Days)
  • CRI 1.7M
  • WVE 1.3M
  • Earning Date
  • CRI 04-25-2025
  • WVE 03-04-2025
  • Dividend Yield
  • CRI 7.79%
  • WVE N/A
  • EPS Growth
  • CRI N/A
  • WVE N/A
  • EPS
  • CRI 5.12
  • WVE N/A
  • Revenue
  • CRI $2,844,102,000.00
  • WVE $108,302,000.00
  • Revenue This Year
  • CRI N/A
  • WVE N/A
  • Revenue Next Year
  • CRI $0.35
  • WVE $33.28
  • P/E Ratio
  • CRI $8.02
  • WVE N/A
  • Revenue Growth
  • CRI N/A
  • WVE N/A
  • 52 Week Low
  • CRI $38.84
  • WVE $4.25
  • 52 Week High
  • CRI $84.16
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • CRI 40.66
  • WVE 31.52
  • Support Level
  • CRI $39.95
  • WVE $9.43
  • Resistance Level
  • CRI $42.70
  • WVE $10.91
  • Average True Range (ATR)
  • CRI 1.49
  • WVE 0.63
  • MACD
  • CRI 0.39
  • WVE -0.18
  • Stochastic Oscillator
  • CRI 57.51
  • WVE 3.21

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: